Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 15.86M | 22.60M | 22.68M | 20.38M | 32.41M |
| Total Depreciation and Amortization | 2.78M | 1.12M | 1.17M | 1.23M | 1.30M |
| Total Amortization of Deferred Charges | 22.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -186.00K | -3.48M | -3.84M | -2.34M | -17.62M |
| Change in Net Operating Assets | -5.39M | -3.20M | -6.24M | -3.28M | -1.13M |
| Cash from Operations | 13.08M | 17.05M | 13.77M | 16.00M | 14.95M |
| Capital Expenditure | -80.06M | -38.00K | -27.00K | -21.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -123.00K | -123.00K | -123.00K | -123.00K | -- |
| Cash from Investing | -80.18M | -161.00K | -150.00K | -144.00K | 0.00 |
| Total Debt Issued | 40.00M | -- | -- | -- | -- |
| Total Debt Repaid | -199.00K | -122.00K | -114.00K | -111.00K | -99.00K |
| Issuance of Common Stock | 333.00K | 457.00K | 466.00K | 426.00K | 275.00K |
| Repurchase of Common Stock | -5.28M | -5.41M | -5.66M | -5.56M | -667.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -398.00K | -- | -- | -- | -- |
| Cash from Financing | 34.46M | -5.07M | -5.31M | -5.24M | -491.00K |
| Foreign Exchange rate Adjustments | 83.00K | -165.00K | 248.00K | 379.00K | 153.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.56M | 11.65M | 8.55M | 10.99M | 14.61M |
